• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • About
    • Contact
    • Privacy
    • Terms of use
  • Advertise
    • Advertising
    • Case studies
    • Design
    • Email marketing
    • Features list
    • Lead generation
    • Magazine
    • Press releases
    • Publishing
    • Sponsor an article
    • Webcasting
    • Webinars
    • White papers
    • Writing
  • Subscribe to Newsletter

Robotics & Automation News

Where Innovation Meets Imagination

  • Home
  • News
  • Features
  • Editorial Sections A-Z
    • Agriculture
    • Aircraft
    • Artificial Intelligence
    • Automation
    • Autonomous vehicles
    • Business
    • Computing
    • Construction
    • Culture
    • Design
    • Drones
    • Economy
    • Energy
    • Engineering
    • Environment
    • Health
    • Humanoids
    • Industrial robots
    • Industry
    • Infrastructure
    • Investments
    • Logistics
    • Manufacturing
    • Marine
    • Material handling
    • Materials
    • Mining
    • Promoted
    • Research
    • Robotics
    • Science
    • Sensors
    • Service robots
    • Software
    • Space
    • Technology
    • Transportation
    • Warehouse robots
    • Wearables
  • Press releases
  • Events

ABB robots help tackle Covid by automating testing, research and diagnostics

February 6, 2023 by Mark Allinson

ABB Robotics has developed an automated neutralizing antibody testing system with the University of Texas Medical Branch (UTMB) that is the most effective means of determining an individual’s immunity to various strains of Covid.

Developed by ABB Robotics, Life Sciences and Healthcare Lab, located at the Texas Medical Center Campus in Houston, Texas, the system dramatically increases the number of neutralizing antibody tests performed, from 15 to over 1,000 daily.

With a greater number of people assessed for immunity against the different strains of the Covid virus, automating the testing will help UTMB researchers gain a greater understanding of the effectiveness of Covid vaccines.

The continued mutation of the Covid virus since its first appearance in late 2019 has presented a major challenge for both medical researchers and governments, as both find ways to control and limit its spread.

Although numerous vaccinations have been developed, the rapid mutation of the virus makes finding the most effective protection against each variant more challenging.

Dr Michael Laposata, professor and chairman of the department of Pathology at UTMB, says: “The ability to carry out more daily tests is the key to generating more data on individual immunity profiles that will help control the further spread of the virus.

“By transforming the rate at which testing can be carried out and eliminating the need for large numbers of laboratory staff being exposed to the potential risk of infection in manual testing, the automated system we’ve developed with ABB provides an accurate, fast, flexible and safe way of meeting our goals.”

The aim of the automated neutralizing antibody test is to specifically detect a SARS-CoV-2 neutralizing antibody without cross-reaction with other infection, making this assay a gold standard for Covid-19 serological testing.

The resulting data will then be used both by the person being tested and by researchers to better understand immunity from vaccination or infection. The data will also inform local policymakers’ decisions on how to minimize the risk of further infection, such as avoiding virus hotspots.

Daniel Navarro, managing director of consumer segments and service robotics at ABB, says: “This project is a clear example of how robotics can increase speed and efficiency, while making work safer for the researchers involved.

“Working closely with UTMB, we are combining our expertise on biology, lab process, automation and software to develop and deploy an automated robotic solution that significantly advances and informs our response to the Covid pandemic.

The automated neutralizing antibody test was developed using the RobotStudio offline programming software to model, iterate and test different combinations of lab equipment and robot positions to develop the most effective working concept.

As a result of this process, a working system was produced from inception into operation within just 18 months, greatly cutting the amount of time typically required for a project of this type.

Juan Garcia, director of Laboratory Services at UTMB, says: “What we managed to achieve in this project within such a short space of time is extraordinary – many multimillion-dollar companies take several years to create solutions like the one we’ve developed in a fraction of the time.”

Laposata says: “None of what we’ve achieved could have been done without ABB or any of the other parties involved in this project.

“From the creation and simulation of a working concept in RobotStudio software through to delivering the physical automated testing cells that are now in use in our laboratory, this is the greatest experience of teamwork I have witnessed in 35 years in this business.”

A further benefit of the automated system is its ability to be used for other types of virus testing. The project is just one of several projects worldwide where ABB robots are being used to help find ways to protect against Covid.

Print Friendly, PDF & Email

Share this:

  • Click to print (Opens in new window) Print
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on X (Opens in new window) X
  • Click to share on Tumblr (Opens in new window) Tumblr
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Telegram (Opens in new window) Telegram
  • Click to share on Pocket (Opens in new window) Pocket

Related stories you might also like…

Filed Under: Features, Science Tagged With: abb, antibody, automated, covid, data, developed, effective, help, immunity, infection, medical, neutralizing, project, researchers, robotics, software, system, test, testing, texas, utmb, virus, working

Primary Sidebar

Search this website

Latest articles

  • Japanese space agency awards GITAI contract to develop unique robotic arm
  • Why Rockwell Automation’s share price has surged more than 30 percent since April
  • Why space factories may be the next industrial frontier, and who’s building them
  • World’s tallest 3D-printed tower unveiled in Swiss Alps
  • Dürr’s 19,000th robot to be delivered to Chinese automaker BYD’s first European plant
  • Global space economy market to surpass $511 billion in 2029, forecasts GlobalData
  • Omron’s Stuttgart Automation Center wins 2025 iF Design Award
  • Doosan Robotics intensifies humanoid development in AI-driven strategic shift
  • Apple reportedly exploring new human-robot training method using Vision Pro
  • Renowned futurist Ray Kurzweil reportedly raising $100 million to build humanoid robots

Secondary Sidebar

Copyright © 2025 · News Pro on Genesis Framework · WordPress · Log in

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT